Advertisement.

IVBXF Projected Dividend Yield

Ord USD/Innovent Biologics Inc ( OTCBB : IVBXF )

Innovent Biologics is a biopharmaceutical company engaged in the development and commercialization of biologic therapies. Co. has developed a fully-integrated platform that has enabled it to build a robust pipeline of monoclonal antibodies and other biologics in the fields of oncology, ophthalmology, and autoimmune and metabolic diseases. Co.'s pipeline of 17 antibody drug candidates are led by its four core products that are in late-stage clinical development in China, including sintilimab (IBI-308), Co.'s PD-1 antibody; IBI-305, Co.'s bevacizumab (Avastin) biosimilar; IBI-301, its rituximab (MabThera/Rituxan) biosimilar; and IBI-303, Co.'s adalimumab (Humira) biosimilar.

21 YEAR PERFORMANCE RESULTS

IVBXF Dividend History Detail
IVBXF Dividend News
IVBXF Competitors News

# of Shares: 0

Closing Price: 6.20

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000